Senaparib group:NA

2 trials

Sponsors

The Second Affiliated Hospital of Zhejiang University School of Medicine, Peking Union Medical College Hospital

Conditions

advanced epithelial ovarian cancer, fallopian tube cancer or primary peritoneal canceradvanced ovarian cancer, fallopian tube cancer, or primary peritoneal cancer

Phase 4

A real-world study on the use of Senaparib for first-line maintenance treatment of newly diagnosed BRCAwt advanced epithelial ovarian cancer, primary peritoneal cancer or fallopian tube cancer

Active, not recruitingChiCTR2600117526

The Second Affiliated Hospital of Zhejiang University School of Medicineadvanced epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer

Start: 2026-01-31Updated: 2026-02-02

Real-World Study of Senaparib for First-Line Maintenance Therapy in Patients with Newly Diagnosed Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Active, not recruitingChiCTR2600120564

Peking Union Medical College Hospitaladvanced ovarian cancer, fallopian tube cancer, or primary peritoneal cancer

Start: 2026-03-18Updated: 2026-03-23